Modeling of electric field distribution in tissues during electroporation

BioMedical Engineering OnLine

Selma Corovic²  Igor Lackovic³  Primoz Sustaric¹  Tomaz Sustar¹  Tomaz Rodic¹  Damijan Miklavcic² 

[1] C3M, d. o. o., Centre for Computational Continuum Mechanics, Technological Park 21, SI-1000 Ljubljana, Slovenia

[2] University of Ljubljana, Faculty of Electrical Engineering, Trzaska cesta 25, SI-1000 Ljubljana Slovenia

[3] University of Zagreb, Faculty of Electrical Engineering and Computing, Unska 3, HR-10000, Zagreb, Croatia

关键词: Tumor electroporation;    Liver electroporation;    Tissue conductivity;    Electric field distribution;    Inverse analysis;    Numerical modeling;    Electroporation;   

Others  :  797937
DOI  :  10.1186/1475-925X-12-16

 received in 2012-08-30, accepted in 2012-12-10,  发布年份 2013

【 摘 要 】

Background

Electroporation based therapies and treatments (e.g. electrochemotherapy, gene electrotransfer for gene therapy and DNA vaccination, tissue ablation with irreversible electroporation and transdermal drug delivery) require a precise prediction of the therapy or treatment outcome by a personalized treatment planning procedure. Numerical modeling of local electric field distribution within electroporated tissues has become an important tool in treatment planning procedure in both clinical and experimental settings. Recent studies have reported that the uncertainties in electrical properties (i.e. electric conductivity of the treated tissues and the rate of increase in electric conductivity due to electroporation) predefined in numerical models have large effect on electroporation based therapy and treatment effectiveness. The aim of our study was to investigate whether the increase in electric conductivity of tissues needs to be taken into account when modeling tissue response to the electroporation pulses and how it affects the local electric distribution within electroporated tissues.

Methods

We built 3D numerical models for single tissue (one type of tissue, e.g. liver) and composite tissue (several types of tissues, e.g. subcutaneous tumor). Our computer simulations were performed by using three different modeling approaches that are based on finite element method: inverse analysis, nonlinear parametric and sequential analysis. We compared linear (i.e. tissue conductivity is constant) model and non-linear (i.e. tissue conductivity is electric field dependent) model. By calculating goodness of fit measure we compared the results of our numerical simulations to the results of in vivo measurements.

Results

The results of our study show that the nonlinear models (i.e. tissue conductivity is electric field dependent: σ(E)) fit experimental data better than linear models (i.e. tissue conductivity is constant). This was found for both single tissue and composite tissue. Our results of electric field distribution modeling in linear model of composite tissue (i.e. in the subcutaneous tumor model that do not take into account the relationship σ(E)) showed that a very high electric field (above irreversible threshold value) was concentrated only in the stratum corneum while the target tumor tissue was not successfully treated. Furthermore, the calculated volume of the target tumor tissue exposed to the electric field above reversible threshold in the subcutaneous model was zero assuming constant conductivities of each tissue.

Our results also show that the inverse analysis allows for identification of both baseline tissue conductivity (i.e. conductivity of non-electroporated tissue) and tissue conductivity vs. electric field (σ(E)) of electroporated tissue.

Conclusion

Our results of modeling of electric field distribution in tissues during electroporation show that the changes in electrical conductivity due to electroporation need to be taken into account when an electroporation based treatment is planned or investigated. We concluded that the model of electric field distribution that takes into account the increase in electric conductivity due to electroporation yields more precise prediction of successfully electroporated target tissue volume. The findings of our study can significantly contribute to the current development of individualized patient-specific electroporation based treatment planning.

【 授权许可】

   
2013 Corovic et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

【 参考文献 】

• [1]Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH: Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982, 1:841-845.
• [2]Pavlin M, Kanduser M, Rebersek M, Pucihar G, Hart FX, Magjarevic R, Miklavcic D: Effect of cell electroporation on the conductivity of a cell suspension. Biophys J 2005, 88:4378-4390.
• [3]Kotnik T, Pucihar G, Miklavcic D: Induced transmembrane voltage and its correlation with electroporation-mediated molecular transport. J Membrane Biol 2010, 236:3-13.
• [4]Pucihar G, Krmelj J, Rebersek M, Napotnik TB, Miklavcic D: Equivalent Pulse Parameters for Electroporation. IEEE T Biomed Eng 2011, 58:3279-3288.
• [5]Teissié J, Rols MP: An experimental evaluation of the critical potential difference inducing cell membrane electropermeabilization. Biophys J 1993, 65(1):409-413.
• [6]Cemazar M, Jarm T, Miklavcic D, Macek Lebar A, Ihan A, Kopitar NA, Sersa G: Effect of electric-field intensity on electropermeabilization and electrosensitivity of various tumor-cell lines in vitro. Electro Magnetobiol 1998, 17:263-272.
• [7]Valic B, Golzio M, Pavlin M, Schatz A, Faurie C, Gabriel B, Teissie J, Rols MP, Miklavcic D: Effect of electric field induced transmembrane potential on spheroidal cells: theory and experiments. Eur Biophys J 2003, 32:519-528.
• [8]Pucihar G, Kotnik T, Valic B, Miklavcic D: Numerical determination of transmembrane voltage induced on irregularly shaped cells. Annals Biomed Eng 2006, 34:642-652.
• [9]Corovic S, Zupanic A, Kranjc S, Al Sakere B, Leroy-Willig A, Mir LM, Miklavcic D: The influence of skeletal muscle anisotropy on electroporation: in vivo study and numerical modeling. Med Biol Eng Comput 2010, 48:637-648.
• [10]Prud’homme GJ, Glinka Y, Khan AS, Draghia-Akli R: Electroporation enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 2006, 6:243-273.
• [11]Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G: The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 1998, 74:2152-2158.
• [12]Kotnik T, Bobanovic F, Miklavcic D: Sensitivity of transmembrane voltage induced by applied electric fields – a theoretical analysis. Bioelectrochem Bioenerg 1997, 43:285-291.
• [13]Miklavcic D, Corovic S, Pucihar G, Pavselj N: Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. Eur J Cancer 2006, 4(Suppl):45-51.
• [14]Rols MP, Teissié J: Electropermeabilization of mammalian cells, Quantitative analysis of the phenomenon. Biophys J 1990, 58(5):1089-1098.
• [15]Miklavcic D, Semrov D, Mekid H, Mir LM: A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000, 1523:73-83.
• [16]Corovic S, Mir LM, Miklavcic D: In vivo muscle electroporation threshold determination: realistic numerical models and in vivo experiments. J Membrane Biol 2012, 245:509-520.
• [17]Davalos RV, Mir LM, Rubinsky B: Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005, 33:223.
• [18]Rubinsky J, Onik G, Mikus P, Rubinsky B: Optimal parameters for the destruction of prostate cancer using irreversible electroporation. J Urol 2008, 180:2668-2674.
• [19]Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM: Tumor ablation with irreversible electroporation. PlosOne 2007, 2:1135.
• [20]Vorobiev E, Lebovka N: Electrotechnologies for Extraction from Food Plants and Biomaterials. New York: Springer Science; 2008.
• [21]Sack M, Sigler J, Frenzel S, Chr E, Arnold J, Michelberger T, Frey W, Attmann F, Stukenbrock L, Mueller G: Research on Industrial-Scale Electroporation Devices Fostering the Extraction of Substances from Biological Tissue. Food Eng Rev 2010, 2:147-156.
• [22]Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R, Teissie J: Electrochemotherapy in veterinary oncology. J Vet Intern Med 2008, 22(4):826-831.
• [23]Testori A, Tosti G, Martinoli C, Spadola G, Cataldo F, Verrecchia F, Baldini F, Mosconi M, Soteldo J, Tedeschi I, Passoni C, Pari C, Di Pietro A, Ferrucci PF: Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach. Dermatol Ther 2010, 23(6):651-661.
• [24]Cemazar M, Jarm T, Sersa G: Cancer electrogene therapy with interleukin-12. Curr Gene Ther 2010, 10(4):300-311.
• [25]Heller LC, Heller R: Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 2010, 10(4):312-317.
• [26]Neal RE II, Rossmeisl JH Jr, Garcia PA, Lantz O, Henao-Guerrero N, Davalos RV: Successful treatment of a large soft-tissue sarcoma with irreversible electroporation. J Clin Oncol 2011, 29(13):372-377.
• [27]Sersa G, Cufer T, Paulin Kosir S, Cemazar M, Snoj M: Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treat Rev 2012, 38(5):379-386.
• [28]Morales-de La Peña M, Elez-Martínez P, Martín-Belloso O: Food preservation by pulsed electric fields: an engineering perspective. Food Eng Rev 2011, 3:94-107.
• [29]Rieder A, Schwartz T, Schön-Hölz K, Marten SM, Süß J, Gusbeth C, Kohnen W, Swoboda W, Obst U, Frey W: Molecular monitoring of inactivation efficiencies of bacteria during pulsed electric field (PEF) treatment of clinical wastewater. J Appl Microbiol 2008, 105:2035-2045.
• [30]Campana LG, Valpione S, Mocellin S, Sundararajan R, Granziera E, Sartore L, Chiarion-Sileni V, Rossi CR: Electrochemotherapy for disseminated superficial metastases from malignant melanoma. BJS 2012, 99:821-830.
• [31]Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, Ricke J, Liehr UB: Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 2011, 34(1):132-138.
• [32]Onik G, Rubinsky B: Irreversible electroporation: First patient experience—Focal therapy of prostate cancer. In Irreversible Electroporation. Edited by Rubinsky B. Heidelberg, Germany: Springer Berlin; 2010:235-247.
• [33]Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL, Heller R: Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008, 26:896-903.
• [34]Ahmad S, Casey G, Sweeney P, Tangney M, O'Sullivan GC: Optimized electroporation mediated DNA vaccination for treatment of prostate cancer. Genet Vaccines Ther 2010, 8:1. BioMed Central Full Text
• [35]Mir LM: Bases and rationale of the electrochemotherapy. EJC 2006, 4(Suppl):38-44.
• [36]Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, Vecchiato A, Corti L, Rossi CR, Nitti D: Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 2009, 16(1):191-199.
• [37]Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessell G, Humphreys AC, Bond JE, Muir T, Gehl J: Management of cutaneous metastases using electrochemotherapy. Acta Oncol 2011, 50(5):621-629.
• [38]Gargiulo M, Papa A, Capasso P, Moio M, Cubicciotti E, Parascandolo S: Electrochemotherapy for non-melanoma head and neck cancers: clinical outcomes in 25 patients. Ann Surg 2012, 255(6):1158-1164.
• [39]Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, Bracko M, Pecnik T, Gadzijev E, Sersa G: Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 2010, 9:10. BioMed Central Full Text
• [40]Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, Mali B, Jarm T, Pavliha D, Marcan M, Gasljevic G, Gorjup V, Music M, Pecnik Vavpotic T, Cemazar M, Snoj M, Sersa G: Electrochemotherapy: A new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 2011, 10:475-485.
• [41]Corovic S, Al-Sakere B, Haddad V, Miklavcic D, Mir LM: Importance of contact surface between electrodes and treated tissue in electrochemotherapy. Technol Cancer Res Treat 2008, 7:393-400.
• [42]Ivorra A, Al-Sakere B, Rubinsky B, Mir LM: Use of conductive gels for electric field homogenization increases the antitumor efficacy of electroporation therapies. Phys Med Biol 2008, 53:6605-6618.
• [43]Kos B, Zupanic A, Kotnik T, Snoj M, Sersa G, Miklavcic D: Robustness of treatment planning for electrochemotherapy of deep-seated tumors. J Membrane Biol 2010, 236:147-153.
• [44]Pavliha D, Kos B, Zupanic A, Marcan M, Sersa G, Miklavcic D: Patient-specific treatment planning of electrochemotherapy: Procedure design and possible pitfalls. Bioelectrochemistry 2012, 87:265-273.
• [45]Fini M, Tschon M, Alberghini M, Bianchi G, Mercuri M, Campanacci L, Cavani F, Ronchetti M, De Terlizzi F, Cadossi R: Cell electroporation in bone tissue. In Clinical aspects of electroporation. Edited by Kee ST, Gehl J, Lee EW. New York: Springer; 2011:115-127.
• [46]Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS, Gehl J: Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 2011, 71(11):3753-3762.
• [47]Garcia PA, Pancotto T, Rossmeisl JH, Henao-Guerrero N, Gustafson NR, Daniel GB, Robertson JL, Ellis TL, Davalos RV: Non-Thermal Irreversible Electroporation (N-TIRE) and Adjuvant Fractionated Radiotherapeutic Multimodal Therapy for Intracranial Malignant Glioma in a Canine Patient. Technol Cancer Res Treat 2011, 10:73-83.
• [48]Corovic S, Zupanic A, Miklavcic D: Numerical modeling and optimization of electric field distribution in subcutaneous tumor treated with electrochemotherapy using needle electrodes. IEEE T Plasma Sci 2008, 36:1665-1672.
• [49]Zupanic A, Corovic S, Miklavcic D: Optimization of electrode position and electric pulse amplitude in electrochemotherapy. Radiol Oncol 2008, 42:93-101.
• [50]Zupanic A, Corovic S, Miklavcic D, Pavlin M: Numerical optimization of gene electrotransfer into muscle tissue. Biomed Eng Online 2010, 9:66. BioMed Central Full Text
• [51]Zupanic A, Miklavcic D: Optimization and numerical modeling in irreversible electroporation treatment planning. In Irreversible Electroporation. Edited by Rubinsky B. Heidelberg: Springer; 2010:203-222.
• [52]Neal RE II, Garcia PA, Robertson JL, Davalos RV: Experimental characterization and numerical modeling of tissue electrical conductivity during pulsed electric fields for irreversible electroporation treatment planning. IEEE T Biomed Eng 2012, 59(4):1077-1085.
• [53]Garcia PA, Rossmeisl JH, Neal RE, Ellis TL, Olson JD, Henao-Guerrero N, Robertson J, Davalos RV: Intracranial Nonthermal Irreversible Electroporation: In Vivo Analysis. J Membr Biol 2010, 236:127-136.
• [54]Mahmood F, Gehl J: Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. Bioelectrochemistry 2011, 81:10-16.
• [55]Zupanic A, Kos B, Miklavcic D: Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation. Phys Med Biol 2012, 57:5425-5440.
• [56]Cukjati D, Batiuskaite D, André F, Miklavčič D, Mir LM: Real time electroporation control for accurate and safe in vivo non-viral gene therapy. Bioelectrochemistry 2007, 70:501-507.
• [57]Essone Mezeme M, Pucihar G, Pavlin M, Brosseau C, Miklavcic D: A numerical analysis of multicellular environment for modeling tissue electroporation. Appl Phys Lett 2012, 100:143701.
• [58]Sel D, Cukjati D, Batiuskaite D, Slivnik T, Mir LM, Miklavcic D: Sequential finite element model of tissue electropermeabilization. IEEE Trans Biomed Eng 2005, 52:816-27.
• [59]Pavselj N, Bregar Z, Cukjati D, Batiuskaite D, Mir LM, Miklavcic D: The course of tissue permeabilization studied on a mathematical model of a subcutaneous tumor in small animals. IEEE Trans Biomed Eng 2005, 52:1373.
• [60]Gresovnik I: A General Purpose Computational Shell for Solving Inverse and Optimisation Problems - Applications to Metal Forming Processes. PhD Thesis: University of Wales Swansea, UK; 2000.
• [61]Center for Computational Continuum Mechanics (Ljubljana, Slovenia). [http://www.c3m.si webcite]
• [62]Lackovic I, Magjarevic R, Miklavcic D: Incorporating Electroporation-related conductivity changes into models for the calculation of the electric field distribution in tissue. In Proceedings of IFMBE (XII Mediterranean Conference on Medical and Biological Engineering and Computing). Edited by Magjarevic R, Bamidis Panagiotis D, Pallikarakis N. Berlin Heidelberg: Springer; 2010:695-698.
• [63]Giavazzi S, Ganatea MF, Trkov M, Sustarsic P, Rodic T: Inverse determination of viscoelastic properties of human fingertip skin. Materials and Geoenvironment 2010, 57:1-16.
• [64]Korelc J: AceGEN (Multi-language, Multi-environment Numerical Code Generation) – Users manual. 2009. [http://www.fgg.uni-lj.si/symech/ webcite]
• [65]Korelc J: AceFEM ((The Mathematica Finite Element Environment) – Users manual. 2009. [http://www.fgg.uni-lj.si/symech/ webcite]
• [66]Korelc J: Automation of primal and sensitivity analysis of transient coupled problems. Comput Mech 2009, 44:631-649.
• [67]Haemmerich D, Staelin ST, Stai JZ, Tungjitkusolmun S, Mahvi DM, Webster JG: In vivo electrical conductivity of hepatic tumours. Physiol Meas 2003, 24:251-260.
• [68]Gabriel C, Peyman A, Grant EH: Electrical conductivity of tissue at frequencies below 1 MHz. Phys Med Biol 2009, 54:4863-4878.
• [69]Pavselj N, Miklavcic D: A numerical model of permeabilized skin with local transport regions. IEEE T Biomed Eng 2008, 55:1927-1930.
• [70]Corovic S, Pavlin M, Miklavcic D: Analytical and numerical quantification and comparison of the local electric field in the tissue for different electrode configurations. Biomed Eng Online 2007, 6:37. BioMed Central Full Text